[HTML][HTML] Drug retention rates and the safety of Janus kinase inhibitors in elderly patients with rheumatoid arthritis
J Temmoku, M Miyata, E Suzuki, Y Sumichika… - Journal of Clinical …, 2023 - mdpi.com
Background: We examined the real-world drug retention rate and safety data of Janus
kinase inhibitors (JAKis) in elderly patients with rheumatoid arthritis (RA). Methods: This …
kinase inhibitors (JAKis) in elderly patients with rheumatoid arthritis (RA). Methods: This …
Drug Retention Rates and the Safety of Janus Kinase Inhibitors in Elderly Patients with Rheumatoid Arthritis.
J Temmoku, M Miyata, E Suzuki… - Journal of Clinical …, 2023 - europepmc.org
Background We examined the real-world drug retention rate and safety data of Janus kinase
inhibitors (JAKis) in elderly patients with rheumatoid arthritis (RA). Methods This study …
inhibitors (JAKis) in elderly patients with rheumatoid arthritis (RA). Methods This study …
[HTML][HTML] Drug Retention Rates and the Safety of Janus Kinase Inhibitors in Elderly Patients with Rheumatoid Arthritis
J Temmoku, M Miyata, E Suzuki… - Journal of Clinical …, 2023 - ncbi.nlm.nih.gov
Background: We examined the real-world drug retention rate and safety data of Janus
kinase inhibitors (JAKis) in elderly patients with rheumatoid arthritis (RA). Methods: This …
kinase inhibitors (JAKis) in elderly patients with rheumatoid arthritis (RA). Methods: This …
Drug Retention Rates and the Safety of Janus Kinase Inhibitors in Elderly Patients with Rheumatoid Arthritis
J Temmoku, M Miyata, E Suzuki… - Journal of Clinical …, 2023 - search.proquest.com
Background: We examined the real-world drug retention rate and safety data of Janus
kinase inhibitors (JAKis) in elderly patients with rheumatoid arthritis (RA). Methods: This …
kinase inhibitors (JAKis) in elderly patients with rheumatoid arthritis (RA). Methods: This …
Drug Retention Rates and the Safety of Janus Kinase Inhibitors in Elderly Patients with Rheumatoid Arthritis.
J Temmoku, M Miyata, E Suzuki… - Journal of Clinical …, 2023 - search.ebscohost.com
Background: We examined the real-world drug retention rate and safety data of Janus
kinase inhibitors (JAKis) in elderly patients with rheumatoid arthritis (RA). Methods: This …
kinase inhibitors (JAKis) in elderly patients with rheumatoid arthritis (RA). Methods: This …
Drug Retention Rates and the Safety of Janus Kinase Inhibitors in Elderly Patients with Rheumatoid Arthritis
J Temmoku, M Miyata, E Suzuki… - Journal of clinical …, 2023 - pubmed.ncbi.nlm.nih.gov
Background We examined the real-world drug retention rate and safety data of Janus kinase
inhibitors (JAKis) in elderly patients with rheumatoid arthritis (RA). Methods This study …
inhibitors (JAKis) in elderly patients with rheumatoid arthritis (RA). Methods This study …